NCT03641742View on ClinicalTrials.gov

Families-At-risk for Interstitial Lung Disease Study

CompletedOBSERVATIONAL
Enrollment

125

Participants

Timeline

Start Date

January 15, 2018

Primary Completion Date

February 11, 2020

Study Completion Date

July 1, 2023

Conditions
Interstitial Lung DiseaseIdiopathic Pulmonary Fibrosis
Trial Locations (1)

10032

Columbia University Irving Medical Center, New York

All Listed Sponsors
collaborator

University of Washington

OTHER

collaborator

Weill Medical College of Cornell University

OTHER

collaborator

University of Iowa

OTHER

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Columbia University

OTHER

NCT03641742 - Families-At-risk for Interstitial Lung Disease Study | Biotech Hunter | Biotech Hunter